Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Window of Opportunity Strategy for Targeted Pathway Inhibition in Patients With Pancreatic Ductal Adenocarcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04005690
Title field or adapter rule
{'original_value': 'A Window of Opportunity Strategy for Targeted Pathway Inhibition in Patients With Pancreatic Ductal Adenocarcinoma', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:26.514716+00:00
Published At
2026-09-04T00:00:00+00:00
Record Updated At
2026-09-04
Source Retrieved At
2026-10-31T22:17:58.991924+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Locally Advanced Pancreatic Ductal Adenocarcinoma", "Metastatic Pancreatic Ductal Adenocarcinoma", "Stage II Pancreatic Cancer AJCC v8", "Stage III Pancreatic Cancer AJCC v8", "Stage IV Pancreatic Cancer AJCC v8", "Unresectable Pancreatic Ductal Adenocarcinoma", "Borderline Resectable Pancreatic Ductal Adenocarcinoma", "Resectable Pancreatic Ductal Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-09-04", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT04005690"
protocolSection.identificationModule.officialTitle
"A Window of Opportunity Strategy for Targeted Pathway Inhibition in Patients With Pancreatic Ductal Adenocarcinoma"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Locally Advanced Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage II Pancreatic Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Pancreatic Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Pancreatic Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Unresectable Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Borderline Resectable Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Resectable Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Arm Cobimetinib'], 'description': 'Given PO', 'name': 'Cobimetinib', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm Olaparib'], 'description': 'Given PO', 'name': 'Olaparib', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm Onvansertib'], 'description': 'Given PO', 'name': 'Onvansertib', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm Azenosertib'], 'description': 'Given PO', 'name': 'Azenosertib', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm AZD5305'], 'description': 'Given PO', 'name': 'Saruparib', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm Tremelimumab'], 'description': 'Given IV', 'name': 'Tremelimumab', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Cobimetinib (protocolSection.armsInterventionsModule.interventions[].name)
  • Olaparib (protocolSection.armsInterventionsModule.interventions[].name)
  • Onvansertib (protocolSection.armsInterventionsModule.interventions[].name)
  • Azenosertib (protocolSection.armsInterventionsModule.interventions[].name)
  • Saruparib (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.